Jiangsu JLand Biotech

Jiangsu JLand Biotech is a Chinese biotechnology company founded in 2015 that specializes in the development, manufacturing, and commercialization of non-animal-derived recombinant collagen. Utilizing a patented high-density fermentation process based on Pichia pastoris yeast, the company produces high-purity, vegan-certified recombinant human-like collagen (branded as Biollagen) for cosmetic, medical device, and food applications. JLand Biotech operates a vertically integrated business model, offering raw materials, OEM/ODM services, and finished skincare products to over 300 global brands. The company has established key partnerships, notably with Evonik, which invested in JLand and collaborates on marketing its vegan collagen products globally.